Table Of Contents

1. Introduction 38
1.1. Objectives Of The Study 38
1.2. Market Definition 38
1.3. Overview Of Global Surgical Sealants And Adhesives Market 39
1.4. Currency And Pricing 40
1.5. Limitation 40
1.6. Markets Covered 41
2. Market Segmentation 43
2.1. Markets Covered 43
2.2. Geographic Scope 44
2.3. Years Considered For The Study 45
2.4. Currency And Pricing 45
2.5. Research Methodology 46
2.6. Primary Interviews With Key Opinion Leaders 50
2.7. Secondary Sources 51
2.8. Assumptions 51
3. Executive Summary 52
4. Premium Insights 55
5. Regulatory Framework 58
5.1. Overview 58
5.2. Regulatory Procedure 58
5.2.1. Fda 59
5.2.2. Ce Marking 60
?
6. Market Overview 62
6.1. Drivers 64
6.1.1. Rising Need To Manage Blood Loss In Patients 64
6.1.2. Growing Number Of Surgical Procedure 64
6.1.3. Technological Advancements In Surgical Sealants And Adhesives Products 65
6.1.4. Rise In Aging Population And Increase In Chronic Diseases 65
6.1.5. Easy Adoption Due To The Fda And Ce Marking Approval 66
6.2. Restraints 67
6.2.1. High Cost Of Surgical Sealants And Adhesive Products 67
6.3. Opportunities 67
6.3.1. Improving Healthcare System In Emerging Market 67
6.4. Challenges 68
6.4.1. Need Of Skilled Professionals/ Staff 68
6.4.2. Development Of Novel Biomaterial Along With New Properties 68
7. Global Surgical Sealants And Adhesives Market, By Product Type 69
7.1. Overview 70
7.2. Natural/Biological Sealants And Adhesives 75
7.2.1. Polypeptide/Protein-Based Sealants And Adhesives 76
7.2.1.1. Fibrin Based 77
7.2.1.2. Collagen Based 78
7.2.1.3. Gelatin Based 79
7.2.1.4. Albumin Based 80
7.2.2. Polysaccharide Based Sealants And Adhesives 81
7.2.2.1. Chitosan Based 82
7.2.2.2. Other Polysaccharide Based 83
7.2.3. Natural /Biological Sealants And Adhesives Market,
By Origin 84
7.2.3.1. Human Blood Based 85
7.2.3.2. Animal Based 86
7.3. Synthetic And Semisynthetic Sealants And Adhesives 87
7.3.1. Cyanoacrylates 88
7.3.2. Polyethylene Gylcol Based Hydrogel 89
7.3.3. Urethane-Based Adhesives 90
7.3.4. Other Synthetic Sealants And Adhesives 91
8. Global Surgical Sealants And Adhesives Market,
By Application 92
8.1. Overview 93
8.2. Central Nervous System (Cns) Surgeries 95
8.3. General Surgeries 96
8.4. Cardiovascular Surgery 97
8.5. Orthopedic Surgeries 98
8.6. Cosmetic Surgeries 99
8.7. Urological Surgeries 100
8.8. Other Surgeries 101
9. Global Surgical Sealants And Adhesives Market, By Indication 103
9.1. Overview 104
9.2. Surgical Hemostasis 106
9.3. Tissue Sealing 107
9.4. Tissue Engineering 108
10. Global Surgical Sealants And Adhesives Market, By End User 109
10.1. Overview 110
10.2. Hospitals 112
10.3. Clinics 113
10.4. Ambulatory Centers 114
10.5. Community Healthcare 115
11. Global Surgical Sealants And Adhesives Market,
By Distribution Channel 116
11.1. Overview 117
11.2. Direct Tender 119
11.3. Retail 120
12. Global Surgical Sealants And Adhesives Market,
By Geography 121
12.1. Overview 121
12.2. North America 128
12.2.1. U.S. 141
12.2.2. Canada 148
12.2.3. Mexico 155
12.3. Europe Surgical Sealants And Adhesives Market 162
12.3.1. Germany 176
12.3.2. France 183
12.3.3. Italy 190
12.3.4. U.K. 197
12.3.5. Spain 204
12.3.6. Russia 211
12.3.7. Turkey 218
12.3.8. Belgium 225
12.3.9. Netherlands 232
12.3.10. Switzerland 239
12.3.11. Rest Of Europe 246
?
12.4. Asia-Pacific Surgical Sealants And Adhesives Market 247
12.4.1. Japan 262
12.4.2. China 268
12.4.3. South Korea 274
12.4.4. India 280
12.4.5. Australia 287
12.4.6. Singapore 294
12.4.7. Thailand 300
12.4.8. Malaysia 307
12.4.9. Indonesia 314
12.4.10. Philippines 321
12.4.11. Rest Of Asia Pacific 328
12.5. South America 329
12.5.1. Brazil 342
12.5.2. Rest Of South America 349
12.6. Middle East And Africa 350
12.6.1. South Africa 363
12.6.2. Rest Of Middle East And Africa 370
13. Global Surgical Sealants And Adhesives Market,
Company Landscape 371
13.1. Company Share Analysis; Global 371
13.2. Company Share Analysis; North America 372
13.3. Company Share Analysis; Europe 373
13.4. Company Share Analysis; Asia-Pacific 374
?
14. Company Profiles 375
14.1. Baxter 375
14.1.1. Company Overview 375
14.1.2. Revenue Analysis 376
14.1.3. Product Portfolio 377
14.1.4. Recent Developments 377
14.2. Ethicon Us, Llc (Subsidiary Of Johnson & Johnson
Services, Inc) 378
14.2.1. Company Overview 378
14.2.2. Revenue Analysis 378
14.2.3. Product Portfolio 379
14.2.4. Recent Developments 379
14.3. Medtronic 380
14.3.1. Company Overview 380
14.3.2. Revenue Analysis 380
14.3.3. Product Portfolio 381
14.3.4. Recent Developments 381
14.4. Cryolife, Inc. 382
14.4.1. Company Overview 382
14.4.2. Revenue Analysis 382
14.4.3. Product Portfolio 383
14.4.4. Recent Developments 383
14.5. C. R. Bard, Inc. 384
14.5.1. Company Overview 384
14.5.2. Revenue Analysis 384
14.5.3. Product Portfolio 385
14.5.4. Recent Developments 385
?
14.6. B. Braun Melsungen Ag 386
14.6.1. Company Overview 386
14.6.2. Revenue Analysis 386
14.6.3. Product Portfolio 387
14.6.4. Recent Developments 387
14.7. Cohera Medical, Inc. 388
14.7.1. Company Overview 388
14.7.2. Company Snapshot 388
14.7.3. Product Portfolio 388
14.7.4. Recent Developments 389
14.8. Integra Lifesciences Corporation 390
14.8.1. Company Overview 390
14.8.2. Revenue Analysis 390
14.8.3. Product Portfolio 391
14.8.4. Recent Developments 391
14.9. Ocular Therapeutix, Inc. 392
14.9.1. Company Overview 392
14.9.2. Revenue Analysis 392
14.9.3. Product Portfolio 392
14.9.4. Recent Developments 393
14.10. Vivostat A/S 394
14.10.1. Company Overview 394
14.10.2. Company Snapshot 394
14.10.3. Product Portfolio 394
14.10.4. Recent Developments 395
14.11. Sealantis Ltd. 396
14.11.1. Company Overview 396
14.11.2. Company Snapshot 396
14.11.3. Product Portfolio 397
14.11.4. Recent Developments 397
14.12. Cardinal Health 398
14.12.1. Company Overview 398
14.12.2. Revenue Analysis 398
14.12.3. Product Portfolio 399
14.12.4. Recent Developments 399
14.13. Advanced Medical Solution Group Plc. 400
14.13.1. Company Overview 400
14.13.2. Revenue Analysis 400
14.13.3. Product Portfolio 401
14.13.4. Recent Developments 401
15. Related Reports 402